Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck
Marketing
Merck aims to 'outnumber' pulmonary arterial hypertension
Mere weeks after earning the FDA’s signoff on new drug Winrevair to treat PAH, Merck has kicked off an educational campaign around the rare disease.
Andrea Park
Apr 16, 2024 10:37am
Top 20 pharma companies by 2023 revenue
Apr 15, 2024 3:00am
Merck CEO Robert Davis receives 9% pay hike to $20.3M
Apr 12, 2024 10:27am
FDA signs off on Merck’s potential blockbuster Winrevair for PAH
Mar 26, 2024 5:11pm
FDA approves Johnson & Johnson's combo pill Opsynvi for PAH
Mar 25, 2024 11:05am
CDMO PharmaLogic expands deal with radiopharma specialist Ratio
Mar 18, 2024 9:27am